Brief: Active Biotech's Patent For Laquinimod In Eye Disorders To Be Granted In US
Nov 13 (Reuters) - Active Biotech AB publ ACTI.ST :
* PATENT FOR LAQUINIMOD IN EYE DISORDERS WILL BE GRANTED IN
THE US
* PATENT PROVIDES PROTECTION AND MARKET EXCLUSIVITY UNTIL
2040
Source text: ID:nMFN9BkNvz
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))